Literature DB >> 8103417

The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis.

M Kitamoto1, T Nakanishi, S Kira, M Kawaguchi, R Nakashio, S Suemori, G Kajiyama, T Asahara, K Dohi.   

Abstract

BACKGROUND: A precise prognostic factor for small hepatocellular carcinoma (HCC), the diagnosis of which recently has increased in incidence because of the development of diagnostic imaging techniques, is desirable. It has been reported that proliferating cell nuclear antigen (PCNA) would be related to proliferating cells, and thus the PCNA labeling index may provide useful information about the biologic behavior of small HCC.
METHODS: An assessment was made of proliferative activity by immunohistochemical staining using a monoclonal antibody against PCNA in 46 nodules of HCC less than 3 cm in diameter resected from 44 patients. A correlation between PCNA labeling index and clinicopathologic findings or prognosis was sought.
RESULTS: The mean labeling index was 18.7% in HCC and 1.9% in nontumor liver tissue. The labeling index corresponded to the degree of histologic differentiation, and the labeling index of well differentiated HCC was significantly lower (P < 0.05) than that of moderately or poorly differentiated HCC. The incidence of capsule formation in the high labeling index group (labeling index > or = 20%) was significantly higher (P < 0.05) than that in the low labeling index group (labeling index < 20%). A high incidence of capsular and vascular invasion was found in the high labeling index group. The survival rate after resection was significantly higher (P < 0.05) and the recurrence rate significantly lower (P < 0.05) in the low labeling index group than in the high labeling index group.
CONCLUSIONS: The PCNA labeling index was shown to be closely related to histologic characteristics, and proved to be a useful indicator of recurrence and survival in small HCC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103417     DOI: 10.1002/1097-0142(19930915)72:6<1859::aid-cncr2820720612>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma.

Authors:  Guoliang Liu; Xiaodong Huang; Xiaopeng Cui; Jing Zhang; Lixian Wei; Runzhou Ni; Cuihua Lu
Journal:  Med Oncol       Date:  2013-05-22       Impact factor: 3.064

2.  Comparative study on proliferation activity in small hepatocellular carcinoma related to hepatitis virus B and C.

Authors:  S J Yu
Journal:  World J Gastroenterol       Date:  1997-12-15       Impact factor: 5.742

3.  Comparison of the proliferative capacity of adenomatous hyperplasia and well differentiated hepatocellular carcinoma.

Authors:  A Yamashita
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

4.  Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis.

Authors:  M Nolte; M Werner; A Nasarek; H Bektas; R von Wasielewski; J Klempnauer; A Georgii
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

5.  Expression and prognostic role of SKIP in human breast carcinoma.

Authors:  Xiaobing Liu; Qichao Ni; Junfei Xu; Chenyi Sheng; Qingqing Wang; Jinpeng Chen; Shuyun Yang; Hua Wang
Journal:  J Mol Histol       Date:  2013-10-23       Impact factor: 2.611

6.  Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation.

Authors:  J T Nhieu; C A Renard; Y Wei; D Cherqui; E S Zafrani; M A Buendia
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  PPARgamma and Wnt/beta-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations.

Authors:  Ying Jiang; Lin Zou; Chunhui Zhang; Song He; Chun Cheng; Junfei Xu; Weiqi Lu; Yong Zhang; Hua Zhang; Donglin Wang; Aiguo Shen
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-03       Impact factor: 4.553

Review 8.  Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Authors:  An Tang; Mustafa R Bashir; Michael T Corwin; Irene Cruite; Christoph F Dietrich; Richard K G Do; Eric C Ehman; Kathryn J Fowler; Hero K Hussain; Reena C Jha; Adib R Karam; Adrija Mamidipalli; Robert M Marks; Donald G Mitchell; Tara A Morgan; Michael A Ohliger; Amol Shah; Kim-Nhien Vu; Claude B Sirlin
Journal:  Radiology       Date:  2017-11-21       Impact factor: 11.105

9.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Effect of preoperative transcatheter arterial chemoembolization on proliferation of hepatocellular carcinoma cells.

Authors:  En-Hua Xiao; Jing-Qing Li; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.